Presentation TCT 2013 TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience Presenter: Tamim Nazif October 29, 2013
Presentation TCT 2013 TCT-114. Impact of Left Ventricular Function on Outcomes of Transcatheter Aortic Valve Replacement and Medical Therapy in Inoperable Patients with Aortic Stenosis: Insights from... Presenter: Sammy Elmariah October 29, 2013
Presentation TCT 2013 TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial Presenter: Alan Zajarias October 29, 2013
Presentation TCT 2013 TCT-112. Left Ventricular Ejection Fraction Improves Less after Trans-Apical Transcatheter Aortic Valve Replacement Compared to a Trans-Femoral Approach Presenter: William Fearon October 29, 2013
Presentation TCT 2013 TCT-110. Lower risk of severe acute kidney injury in transcatheter aortic valve replacement: intracardiac echocardiography lowers radiocontrast medium requirements Presenter: Thomas Bartel October 29, 2013
Presentation TCT 2013 TCT-109. Prosthetic Valve Infective Endocarditis following Transcatheter Aortic Valve Implantation: the Results of a Retrospective Multicenter Italian Registry Presenter: Charbel Naim October 29, 2013
Presentation TCT 2013 TCT-106. Novel Hemodynamic Index for the Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement Presenter: Baris Bugan October 29, 2013
Presentation TCT 2013 TCT-105. Device-to-Annulus Pre-deployment Angle by Intraoperative Transesophageal Echocardiography Predicts Paravalvular Regurgitation following Transcatheter Aortic Valve... Presenter: Leo Marcoff October 29, 2013
Presentation TCT 2013 Sutureless Surgical Aortic Valves. Any Role in the TAVR Era? Presenter: Rudiger Lange October 29, 2013
Presentation TCT 2013 Procedural Experience and Outcomes in the CoreValve US Extreme Risk Study Presenter: Michael Reardon October 29, 2013
Presentation TCT 2013 Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR? Presenter: Larry Wood October 29, 2013
Presentation TCT 2013 Neurological Events in the CoreValve US Extreme Risk Study Presenter: David Adams October 29, 2013
Presentation TCT 2013 My Most Valuable TAVR Lessons: A Surgeon's Perspective Presenter: Michael Reardon October 29, 2013
Presentation TCT 2013 Largest Single-Center Experience of Percutaneous Left Ventricular Transapical Access for Structural Heart Disease Interventions Presenter: Chad Kliger October 29, 2013
Presentation TCT 2013 Is There Still a Role for Alternative Access in TAVR (Transapical, Other)? Presenter: Thomas Walther October 29, 2013
Presentation TCT 2013 How Important Is Paravalvular Leak After TAVR and Will This Limit Its Penetration? Presenter: Samir Kapadia October 29, 2013
Presentation TCT 2013 Essential TAVR Technique: From Patient Selection and Workup to Access Routes to Indispensable Tips and Trick Presenter: Samir Kapadia October 29, 2013
Presentation TCT 2013 Echocardiographic Results in the CoreValve US Extreme Risk Study: Hemodynamics and Aortic Regurgitation Presenter: Jae Oh October 29, 2013
Presentation TCT 2013 COREVALVE EXTREME RISK: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Self-Expanding Transcatheter Heart Valve in Patients with Severe Aortic... Presenter: Jeffrey Popma October 29, 2013
Presentation TCT 2013 Case Presentations: The Issue: Introducing Two Aortic Stenosis Cases Which Might Invoke Different Approaches (Moderate and High Surgical Risk) Presenter: Isaac George October 29, 2013